Regeneron's Yancopoulos draws boos as he touts pharma innovation over cost considerations

“Please God, society, give us a cure for Alzheimer's” is certainly a statement that most people can get on board with, but the remark from Regeneron’s George Yancopoulos, M.D., Ph.D., landed amid a heated discussion at the Milken Institute conference in which he interrupted the moderator and described her question about paying for experimental, costly treatments as “ludicrous.”